Awarded

INMUNOGLOBULINA HUMANA NORMAL (DOE) INTRAVENOSA AL 5%

Name: INMUNOGLOBULINA HUMANA NORMAL (DOE) INTRAVENOSA AL 5%
Creator: HOSPITAL CLINICO SAN CARLOS
Published: 2026-01-23
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Spanish

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: HOSPITAL CLINICO SAN CARLOS
Winners: Octapharma, S.A.
Contract value: €352,000
Bids received: 1
Published: 23 Jan 2026
Awarded: 20 Jan 2026
Contract start: 20 Jan 2026
Contract end: 6 Feb 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Madrid
Source: Original notice on TED (55408-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
ATOGEPANT (AQUIPTA 60 mg comprimidos 28 comprimidos)	HOSPITAL CLINICO SAN CARLOS	ABBVIE SPAIN, S.L	€243,588	28 Oct 2026
ATOGEPANT (AQUIPTA 10 mg comprimidos 28 comprimidos)	HOSPITAL CLINICO SAN CARLOS	ABBVIE SPAIN, S.L	€12,991	28 Oct 2026
FILSPARI 400 MG COMPRIMIDOS 30 comprimidos	HOSPITAL CLINICO SAN CARLOS	VIFOR PHARMA ESPAÑA S.L.	€253,394	28 Oct 2026
FILSPARI 200 MG COMPRIMIDOS 30 comprimidos	HOSPITAL CLINICO SAN CARLOS	VIFOR PHARMA ESPAÑA S.L.	€9,704	28 Oct 2026
2ª prorroga RINGER LACTADO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICO	HOSPITAL CLINICO SAN CARLOS	FRESENIUS KABI ESPAÑA, S.A.	€17,390	23 Oct 2026
2ª prorroga GLUCOSALINO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN ADMINISTRACIÓN IV FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICO	HOSPITAL CLINICO SAN CARLOS	FRESENIUS KABI ESPAÑA, S.A.	€4,880	23 Oct 2026